1. Home
  2. CELH vs RGEN Comparison

CELH vs RGEN Comparison

Compare CELH & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELH
  • RGEN
  • Stock Information
  • Founded
  • CELH 2004
  • RGEN 1981
  • Country
  • CELH United States
  • RGEN United States
  • Employees
  • CELH N/A
  • RGEN N/A
  • Industry
  • CELH Beverages (Production/Distribution)
  • RGEN Medical/Dental Instruments
  • Sector
  • CELH Consumer Staples
  • RGEN Health Care
  • Exchange
  • CELH Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • CELH 16.6B
  • RGEN 6.5B
  • IPO Year
  • CELH N/A
  • RGEN N/A
  • Fundamental
  • Price
  • CELH $61.90
  • RGEN $151.57
  • Analyst Decision
  • CELH Strong Buy
  • RGEN Buy
  • Analyst Count
  • CELH 18
  • RGEN 11
  • Target Price
  • CELH $64.06
  • RGEN $167.90
  • AVG Volume (30 Days)
  • CELH 4.1M
  • RGEN 1.2M
  • Earning Date
  • CELH 11-07-2025
  • RGEN 10-28-2025
  • Dividend Yield
  • CELH N/A
  • RGEN N/A
  • EPS Growth
  • CELH N/A
  • RGEN N/A
  • EPS
  • CELH 0.39
  • RGEN 0.03
  • Revenue
  • CELH $1,666,480,000.00
  • RGEN $707,890,000.00
  • Revenue This Year
  • CELH $84.78
  • RGEN $16.79
  • Revenue Next Year
  • CELH $30.62
  • RGEN $13.58
  • P/E Ratio
  • CELH $156.83
  • RGEN $5,956.54
  • Revenue Growth
  • CELH 11.85
  • RGEN 11.74
  • 52 Week Low
  • CELH $21.10
  • RGEN $102.97
  • 52 Week High
  • CELH $66.74
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • CELH 54.56
  • RGEN 54.19
  • Support Level
  • CELH $60.85
  • RGEN $155.74
  • Resistance Level
  • CELH $64.09
  • RGEN $169.87
  • Average True Range (ATR)
  • CELH 2.41
  • RGEN 6.33
  • MACD
  • CELH -0.27
  • RGEN -0.26
  • Stochastic Oscillator
  • CELH 30.96
  • RGEN 30.68

About CELH Celsius Holdings Inc.

Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. The firm now owns three energy drink brands: Celsius, Alani Nu, and Rockstar Energy. It dedicates its efforts to product innovation and marketing while outsourcing manufacturing and packaging to third-party co-packers and distribution to PepsiCo. The firm issued convertible preferred shares following PepsiCo's investments in 2022 and 2025, giving the latter an 11% stake in Celsius.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: